Yuyu Pharma (000220) — Cash Flow Reinvestment Rate
Yuyu Pharma (000220) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting ₩1.48 Billion (capex ₩1.46 Billion plus investments ₩-22.80 Million) from operating cash flow of ₩836.62 Million. Explore Yuyu Pharma capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yuyu Pharma Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Yuyu Pharma across 10 annual periods. Also explore 000220 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Yuyu Pharma (2011–2024)
Year-by-year capital reinvestment analysis for Yuyu Pharma. For live market cap and broader valuation context, see 000220 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | ₩9.30 Billion | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.9% |
| 2023 | 17.93x | ₩7.55 Billion | ₩420.86 Million | ₩5.11 Billion | ▲ +1205.4% |
| 2021 | 1.37x | ₩6.19 Billion | ₩4.51 Billion | ₩6.07 Billion | ▲ +108.6% |
| 2019 | 0.66x | ₩8.68 Billion | ₩13.19 Billion | ₩8.06 Billion | ▼ -59.2% |
| 2018 | 1.61x | ₩9.87 Billion | ₩6.11 Billion | ₩9.76 Billion | ▼ -83.4% |
| 2017 | 9.74x | ₩5.46 Billion | ₩561.35 Million | ₩5.19 Billion | ▲ +2433.5% |
| 2016 | 0.38x | ₩3.77 Billion | ₩9.82 Billion | ₩2.32 Billion | ▼ -80.8% |
| 2014 | 2.00x | ₩2.73 Billion | ₩1.36 Billion | ₩404.37 Million | ▲ +1519.0% |
| 2012 | 0.12x | ₩805.15 Million | ₩6.51 Billion | ₩805.15 Million | ▲ +102.1% |
| 2011 | 0.06x | ₩408.49 Million | ₩6.67 Billion | ₩408.49 Million | — |